Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We employ our advanced, specialised process to create targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P10636
UPID:
TAU_HUMAN
Alternative names:
Neurofibrillary tangle protein; Paired helical filament-tau
Alternative UPACC:
P10636; P18518; Q14799; Q15549; Q15550; Q15551; Q1RMF6; Q53YB1; Q5CZI7; Q5XWF0; Q6QT54; Q9UDJ3; Q9UMH0; Q9UQ96
Background:
Microtubule-associated protein tau, known as Neurofibrillary tangle protein or Paired helical filament-tau, plays a pivotal role in promoting microtubule assembly and stability. It is crucial in neuronal polarity establishment and maintenance, acting as a linker between axonal microtubules and neural plasma membrane components. The protein's localization influences axonal polarity, with its isoforms affecting cytoskeleton plasticity and stabilization.
Therapeutic significance:
Tau is implicated in several neurodegenerative diseases, including Frontotemporal dementia, Pick disease of the brain, Progressive supranuclear palsy 1, and Parkinson-dementia syndrome. These conditions are characterized by cognitive decline, memory loss, and motor symptoms, with tau pathology being a common hallmark. Understanding the role of tau in these diseases could lead to novel therapeutic strategies targeting tau pathology to alleviate or halt disease progression.